Curocell Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-39,258	-38,239	-29,575
Depreciation & Amortization	6,146	6,335	4,706
Loss (Gain) From Sale of Assets	-1.24	8.18	11.24
Stock-Based Compensation	1,206	1,522	1,410
Other Operating Activities	1,606	2,258	-1,590
Change in Other Net Operating Assets	-696.06	-306.82	-226.61
Operating Cash Flow	-30,997	-28,422	-25,264
Capital Expenditures	28.83	-441.02	-21,164
Sale of Property, Plant & Equipment	12.55	-	30.91
Sale (Purchase) of Intangibles	-1,733	-768.92	-486.51
Investment in Securities	-1,696	23,500	500
Other Investing Activities	145.91	20	-7.24
Investing Cash Flow	-3,242	22,020	-21,127
Short-Term Debt Issued	-	-	1,000
Long-Term Debt Issued	-	-	46,899
Total Debt Issued	43,000	-	47,899
Short-Term Debt Repaid	-	-	-200
Long-Term Debt Repaid	-	-507.5	-30,201
Total Debt Repaid	-537.37	-507.5	-30,401
Net Debt Issued (Repaid)	42,463	-507.5	17,497
Issuance of Common Stock	1,745	1,556	32,185
Other Financing Activities	-58.33	-6.82	-
Financing Cash Flow	44,149	1,042	49,682
Foreign Exchange Rate Adjustments	20.09	23.53	-
Miscellaneous Cash Flow Adjustments	0	0	-0
Net Cash Flow	9,930	-5,337	3,291
Free Cash Flow	-30,968	-28,863	-46,428
Free Cash Flow Per Share	-2173.07	-2065.28	-3923.32
Cash Interest Paid	1,683	1,921	1,401
Cash Income Tax Paid	-	22.26	38.48
Levered Free Cash Flow	4,442	-18,421	-
Unlevered Free Cash Flow	6,746	-16,794	-
Change in Working Capital	-696.06	-306.82	-226.61

Source: S&P Capital IQ. Standard template. Financial Sources.